According to Eurobio Scientific's latest financial reports the company has a price-to-book ratio of 0.8185.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.9751 | -26.7% |
2022-12-31 | 1.33 | -29.92% |
2021-12-31 | 1.90 | 6.47% |
2020-12-31 | 1.78 | 23.62% |
2019-12-31 | 1.44 | 40.68% |
2018-12-31 | 1.03 | -26.75% |
2017-12-31 | 1.40 | -29.56% |
2016-12-31 | 1.99 | -4.04% |
2015-12-31 | 2.07 | 8.14% |
2014-12-31 | 1.91 | 2.29% |
2013-12-31 | 1.87 | -7.81% |
2012-12-31 | 2.03 | -22.03% |
2011-12-31 | 2.60 | -26.71% |
2010-12-31 | 3.55 | -24.82% |
2009-12-31 | 4.73 |